PTC Therapeutics (PTCT) PT Raised to $82 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $71.70 -0.38%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $82.00 (from $70.00) while maintaining a Outperform rating.
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Raised to $122 at Barclays
- PTC wins bid for Sangamo's Fabry disease gene therapy in bankruptcy
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
